Viatris Announces Launch of Breyna™ (Budesonide and Formoterol Fumarate Dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People With Asthma and Chronic Obstructive Pulmonary Disease, in Partnership With Kindeva
Viatris Inc. and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application approved by the U.S. Food and Drug Administration (FDA).
Subscribe to